Literature DB >> 6371044

Enzyme-linked immunosorbent assay for evaluation of immunity to measles virus.

K A Weigle, M D Murphy, P A Brunell.   

Abstract

An enzyme-linked immunosorbent assay for the determination of immunity to measles virus was developed and standardized; it was compared to the hemagglutination inhibition and plaque reduction neutralization methods for sensitivity and specificity. The conditions of the enzyme-linked immunosorbent assay were adjusted such that groups of susceptible and immune individuals were clearly separable on the basis of the reactivity of a single (1:100) dilution of their sera to viral and control antigens. The range of values corresponding to susceptibility and immunity was defined by using the distribution of values observed from testing sera obtained from susceptible and immune control groups. The enzyme-linked immunosorbent assay was then applied in a study of measles vaccinees and found to be more sensitive than the hemagglutination inhibition method and equal in sensitivity to the plaque reduction neutralization method. The three methods were equal in specificity. Thus, the measles virus enzyme-linked immunosorbent assay is a rapid, reproducible, sensitive, and specific method for screening for the presence of measles antibody.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6371044      PMCID: PMC271068          DOI: 10.1128/jcm.19.3.376-379.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

Review 1.  Measles vaccine failure. A survey of causes and means of prevention.

Authors:  G F Hayden
Journal:  Clin Pediatr (Phila)       Date:  1979-03       Impact factor: 1.168

2.  Measles immunization. Successes and failures.

Authors:  A S Yeager; J H Davis; L A Ross; B Harvey
Journal:  JAMA       Date:  1977-01-24       Impact factor: 56.272

3.  Progress in measles elimination.

Authors:  A R Hinman; D L Eddins; C D Kirby; W A Orenstein; R H Bernier; P M Turner; A B Bloch
Journal:  JAMA       Date:  1982-03-19       Impact factor: 56.272

4.  Comparison of enzyme-linked immunosorbent assay for acute measles with hemagglutination inhibition complement fixation, and fluorescent-antibody methods.

Authors:  M B Kleiman; C K Blackburn; S E Zimmerman; M L French
Journal:  J Clin Microbiol       Date:  1981-08       Impact factor: 5.948

5.  Enzyme-immunoassays for antibodies in measles, cytomegalovirus infections and after rubella vaccination.

Authors:  A Voller; D E Bidwell
Journal:  Br J Exp Pathol       Date:  1976-04

6.  Role of virus strain in conventional and enhanced measles plaque neutralization test.

Authors:  P Albrecht; K Herrmann; G R Burns
Journal:  J Virol Methods       Date:  1981-12       Impact factor: 2.014

7.  Appearance and persistence of antibodies against different virus components after regular measles infections.

Authors:  E Norrby; Y Gollmar
Journal:  Infect Immun       Date:  1972-09       Impact factor: 3.441

8.  Detection of IgG antibodies specific for measles virus by enzyme-linked immunosorbent assay (ELISA).

Authors:  S Kahane; V Goldstein; I Sarov
Journal:  Intervirology       Date:  1979       Impact factor: 1.763

9.  Antigen requirements, sensitivity, and specificity of enzyme immunoassays for measles and rubella viral antibodies.

Authors:  B Forghani; N J Schmidt
Journal:  J Clin Microbiol       Date:  1979-06       Impact factor: 5.948

10.  Enzyme-linked immunosorbent assay for detection of measles antibody.

Authors:  W L Boteler; P M Luipersbeck; D A Fuccillo; A J O'Beirne
Journal:  J Clin Microbiol       Date:  1983-05       Impact factor: 5.948

View more
  12 in total

1.  Response to measles-mumps-rubella vaccine in children on dialysis.

Authors:  S L Schulman; A Deforest; B A Kaiser; M S Polinsky; H J Baluarte
Journal:  Pediatr Nephrol       Date:  1992-03       Impact factor: 3.714

2.  Measles antibody prevalence after mass immunization in São Paulo, Brazil.

Authors:  C S Pannuti; J C Moraes; V A Souza; M C Camargo; N T Hidalgo
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

3.  Immunosorbent assay based on recombinant hemagglutinin protein produced in a high-efficiency mammalian expression system for surveillance of measles immunity.

Authors:  F Bouche; W Ammerlaan; F Berthet; S Houard; F Schneider; C P Muller
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

4.  Human leukocyte antigen associations with humoral and cellular immunity following a second dose of measles-containing vaccine: persistence, dampening, and extinction of associations found after a first dose.

Authors:  Robert M Jacobson; Inna G Ovsyannikova; Robert A Vierkant; V Shane Pankratz; Gregory A Poland
Journal:  Vaccine       Date:  2011-08-26       Impact factor: 3.641

5.  Comparison of measles antihemolysin test, enzyme-linked immunosorbent assay, and hemagglutination inhibition test with neutralization test for determination of immune status.

Authors:  P W Neumann; J M Weber; A G Jessamine; M V O'Shaughnessy
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

6.  Evaluation of a two-dose measles, mumps, and rubella vaccination schedule in a cohort of college athletes.

Authors:  T R Coté; D Sivertson; J M Horan; M L Lindegren; D M Dwyer
Journal:  Public Health Rep       Date:  1993 Jul-Aug       Impact factor: 2.792

7.  Specific immunoglobulin M enzyme-linked immunosorbent assay for confirming the diagnosis of measles.

Authors:  A W Lievens; P A Brunell
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

8.  Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine.

Authors:  Inna G Ovsyannikova; Neelam Dhiman; Robert M Jacobson; Robert A Vierkant; Gregory A Poland
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

9.  Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus.

Authors:  D D Erdman; L J Anderson; D R Adams; J A Stewart; L E Markowitz; W J Bellini
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

10.  Passive hemagglutination test for measles immunity and serodiagnosis.

Authors:  H Sakata; A Sugiura
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.